Lenvaxen 10 mg (Lenvatinib) is an innovative oral medication designed to treat several types of advanced cancers, including thyroid cancer, renal cell carcinoma (RCC), and hepatocellular carcinoma (HCC). The active ingredient, Lenvatinib, is a multi-targeted tyrosine kinase inhibitor (TKI) that works by blocking the signals that promote the growth of cancer cells and the formation of blood vessels that supply…
Sunitix (Sunitinib) is a powerful oral medication used to treat several types of advanced cancers, including renal cell carcinoma (RCC), gastrointestinal stromal tumours (GIST), and pancreatic neuroendocrine tumours (pNET). Sunitinib, the active ingredient in Sunitix, is a multi-targeted tyrosine kinase inhibitor (TKI) that works by blocking the activity of specific enzymes that promote cancer cell growth and angiogenesis. The process…
